UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043077
Receipt number R000049178
Scientific Title Risk of inner ear involvement in patients with inflammatory bowel disease: a population-based cohort study
Date of disclosure of the study information 2021/01/21
Last modified on 2022/01/22 17:48:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Risk of inner ear involvement in patients with inflammatory bowel disease: a population-based cohort study

Acronym

inflammatory bowel disease and hearing loss/vertigo

Scientific Title

Risk of inner ear involvement in patients with inflammatory bowel disease: a population-based cohort study

Scientific Title:Acronym

inflammatory bowel disease and hearing loss/vertigo

Region

Japan


Condition

Condition

Hearing loss and balance disorders

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the relationship between inflammatory bowel disorders and hearing loss/dizziness.

Basic objectives2

Others

Basic objectives -Others

To reveal a prevalence of hearing loss/dizziness in patients with inflammatory bowel diseases.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

A prevalence of hearing loss/dizziness in patients with inflammatory bowel diseases based on questionnaire-based survey.

Key secondary outcomes

Audiometric features of hearing loss in patients with inflammatory bowel diseases.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 years-old <

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

All patients with ulcerative colitis/Crohn's disease who are under follow-up in Tokyo Medical and Dental University Hospital.

Key exclusion criteria

Patients who have difficulty in expressing willingness to participate in this clinical study.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Taro
Middle name
Last name Fujikawa

Organization

Tokyo Medical and Dental University

Division name

Otolaryngology

Zip code

113-8519

Address

1-5-45, Bunkyo-ku, Yushima, Tokyo, Japan

TEL

03-5308-5308

Email

fujikawa.oto@tmd.ac.jp


Public contact

Name of contact person

1st name Taro
Middle name
Last name Fujikawa

Organization

Tokyo Medical and Dental University

Division name

Otolaryngology

Zip code

113-8519

Address

1-5-45, Bunkyo-ku, Yushima, Tokyo, Japan

TEL

03-5308-5308

Homepage URL


Email

fujikawa.oto@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical and Dental University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Medical and Dental University Hospital of Medicine, Clinical Research Center

Address

1-5-45, Bunkyo-ku, Yushima, Tokyo, Japan

Tel

03-5308-5612

Email

tiken.crc@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科歯科大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

500

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 09 Month 08 Day

Date of IRB

2020 Year 10 Month 01 Day

Anticipated trial start date

2020 Year 10 Month 12 Day

Last follow-up date

2022 Year 04 Month 30 Day

Date of closure to data entry

2022 Year 04 Month 30 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

622 patients were registered. Audiometry was performed for 421 patients.


Management information

Registered date

2021 Year 01 Month 21 Day

Last modified on

2022 Year 01 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049178


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name